Literature DB >> 1563802

A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages.

R B Lorsbach1, S W Russell.   

Abstract

Nitric oxide production by macrophages required either simultaneous or sequential exposure to gamma interferon and lipopolysaccharide; exposure to lipopolysaccharide followed by exposure to gamma interferon gave little response. The apparently evanescent nature of the lipopolysaccharide signal, necessitating persistent stimulation, could be essential to down-regulating nitric oxide production after bacteria are cleared in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563802      PMCID: PMC257128          DOI: 10.1128/iai.60.5.2133-2135.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

2.  Heterogeneity among macrophages cultured from mouse bone marrow. Morphologic, cytochemical and flow cytometric analyses.

Authors:  K P Leung; S W Russell; P A LeBlanc; S Caballero
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

4.  Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

5.  Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.

Authors:  S M Taffet; S W Russell
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

6.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

7.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

8.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.

Authors:  L B Adams; S G Franzblau; Z Vavrin; J B Hibbs; J L Krahenbuhl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA.

Authors:  N Takasuka; T Tokunaga; K S Akagawa
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

10.  Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism.

Authors:  P Vincendeau; S Daulouède
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

View more
  16 in total

1.  The gills are an important site of iNOS expression in rainbow trout Oncorhynchus mykiss after challenge with the gram-positive pathogen Renibacterium salmoninarum.

Authors:  J J Campos-Perez; M Ward; P S Grabowski; A E Ellis; C J Secombes
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 2.  Nitric oxide.

Authors:  A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

3.  Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation.

Authors:  O Goureau; M Lepoivre; F Becquet; Y Courtois
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production.

Authors:  J H Martin; S W Edwards
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.

Authors:  Y Nakano; T Kasahara; N Mukaida; Y C Ko; M Nakano; K Matsushima
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Preexposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide response to secondary stimuli.

Authors:  H Fahmi; P Ancuta; S Perrier; R Chaby
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

8.  Resistance of Haemophilus influenzae to reactive nitrogen donors and gamma interferon-stimulated macrophages requires the formate-dependent nitrite reductase regulator-activated ytfE gene.

Authors:  Jane C Harrington; Sandy M S Wong; Charles V Rosadini; Oleg Garifulin; Victor Boyartchuk; Brian J Akerley
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

9.  Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.

Authors:  L Proudfoot; A V Nikolaev; G J Feng; W Q Wei; M A Ferguson; J S Brimacombe; F Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages.

Authors:  E Michaliszyn; S Sénéchal; P Martel; L de Repentigny
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.